Next Article in Journal
Pharmacognostic and Antioxidant Properties of Dracaena sanderiana Leaves
Next Article in Special Issue
Tart Cherry Extracts Reduce Inflammatory and Oxidative Stress Signaling in Microglial Cells
Previous Article in Journal
Antioxidant Properties of Water-Soluble Gum from Flaxseed Hulls
Previous Article in Special Issue
Berry Leaves: An Alternative Source of Bioactive Natural Products of Nutritional and Medicinal Value
Article Menu

Export Article

Open AccessReview
Antioxidants 2016, 5(3), 27; doi:10.3390/antiox5030027

Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents

1
Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
2
Department of Food Science and Technology, University of Nebraska, 256 Food Innovation Complex, Lincoln, NE 68588-6205, USA
3
Department of Statistics, University of Nebraska, Lincoln, NE 68583, USA
4
Quantitative Life Sciences Initiative, University of Nebraska, Lincoln, NE 68583, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Dorothy Klimis-Zacas
Received: 30 June 2016 / Revised: 11 August 2016 / Accepted: 15 August 2016 / Published: 18 August 2016
(This article belongs to the Special Issue Berry Antioxidants in Health and Disease)
View Full-Text   |   Download PDF [652 KB, uploaded 18 August 2016]   |  

Abstract

Cranberries are rich in bioactive constituents reported to influence a variety of health benefits, ranging from improved immune function and decreased infections to reduced cardiovascular disease and more recently cancer inhibition. A review of cranberry research targeting cancer revealed positive effects of cranberries or cranberry derived constituents against 17 different cancers utilizing a variety of in vitro techniques, whereas in vivo studies supported the inhibitory action of cranberries toward cancers of the esophagus, stomach, colon, bladder, prostate, glioblastoma and lymphoma. Mechanisms of cranberry-linked cancer inhibition include cellular death induction via apoptosis, necrosis and autophagy; reduction of cellular proliferation; alterations in reactive oxygen species; and modification of cytokine and signal transduction pathways. Given the emerging positive preclinical effects of cranberries, future clinical directions targeting cancer or premalignancy in high risk cohorts should be considered. View Full-Text
Keywords: cranberry; cancer; proanthocyanidin; quercetin; ursolic acid cranberry; cancer; proanthocyanidin; quercetin; ursolic acid
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Weh, K.M.; Clarke, J.; Kresty, L.A. Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents. Antioxidants 2016, 5, 27.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antioxidants EISSN 2076-3921 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top